Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rossi

Showing results (11-20 of 516) with videos related to

Pageof 52
Sort By:
Journal of Thoracic Disease|June 29, 2018
Immunotherapy & thoracic cancersAntonio Rossi, Silvia Novello
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
The Tradition of the Rising Sun: When Geography CountsAntonio Rossi, Silvia Novello
Oncology (Williston Park, N.Y.)|January 1, 2011
Unanswered questions: monoclonal antibodies in the treatment of advanced non-small-cell lung cancerCesare Gridelli, Antonio Rossi
Cancers|February 15, 2022
Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR MutationsAntonio Rossi, Domenico Galetta
Journal of Thoracic Disease|July 27, 2012
EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European populationCesare Gridelli, Antonio Rossi
Frontiers in Endocrinology|June 8, 2026
Editorial: Inflammatory biomarkers in type 1 diabetesJoanna Filipowska, Antonio Rossi
Expert Review of Respiratory Medicine|October 10, 2019
Approved and emerging treatments of malignant pleural mesothelioma in elderly patientsGiovanni Luca Ceresoli, Antonio Rossi
Expert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di Maio
Lung Cancer Management|January 16, 2019
<i>NRG1</i>: a cinderella fusion in lung cancer?Lucia Anna Muscarella, Antonio Rossi
The Lancet. Oncology|January 16, 2015
LUX-Lung: determining the best EGFR inhibitor in NSCLC?Antonio Rossi, Massimo Di Maio
Pageof 52

Showing results (11-20 of 516) with videos related to

Sort By:
Pageof 52
Journal of Thoracic Disease|June 29, 2018
Immunotherapy & thoracic cancersAntonio Rossi, Silvia Novello
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
The Tradition of the Rising Sun: When Geography CountsAntonio Rossi, Silvia Novello
Oncology (Williston Park, N.Y.)|January 1, 2011
Unanswered questions: monoclonal antibodies in the treatment of advanced non-small-cell lung cancerCesare Gridelli, Antonio Rossi
Cancers|February 15, 2022
Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR MutationsAntonio Rossi, Domenico Galetta
Journal of Thoracic Disease|July 27, 2012
EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European populationCesare Gridelli, Antonio Rossi
Frontiers in Endocrinology|June 8, 2026
Editorial: Inflammatory biomarkers in type 1 diabetesJoanna Filipowska, Antonio Rossi
Expert Review of Respiratory Medicine|October 10, 2019
Approved and emerging treatments of malignant pleural mesothelioma in elderly patientsGiovanni Luca Ceresoli, Antonio Rossi
Expert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di Maio
Lung Cancer Management|January 16, 2019
<i>NRG1</i>: a cinderella fusion in lung cancer?Lucia Anna Muscarella, Antonio Rossi
The Lancet. Oncology|January 16, 2015
LUX-Lung: determining the best EGFR inhibitor in NSCLC?Antonio Rossi, Massimo Di Maio
Pageof 52